ACI-12589

N/A

Report date: 2025/11/21 17:16:33
NMEFirst In Class

Base Information

Drug NameACI-12589
Drug Alias NameACI-12589a-syn-PET tracer (AC Immune)[18F]MNI-1216[18F]ACI-12589
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionPositron-emission tomography enhancersSynuclein alpha modulators
TargetsSynuclein alpha
Therapy Area/IndicationsSynucleinopathiesParkinson DiseaseLewy Body Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAc Immune SaBiogen IncInvicro Llc
China Registration ClassN/A

Develop Information

Active CompaniesAc Immune SaBiogen IncInvicro Llc
Inactive CompaniesN/A
Active IndicationsSynucleinopathiesParkinson DiseaseLewy Body Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A